Abstract:BACKGROUND:Identification of biomarkers of pancreatic neuroendocrine tumors (PNETs) is important for stratification of the prognosis. Ki-67 index was the significant prognostic factor for PNETs. Recently, MMP-9, DJ-1, and α-1-B glycoprotein (A1BG) were shown to be the prognostic markers in some malignant tumors except for PNETs. The aim of this study was to compare these tumor markers for predicting disease-free survival in surgically resected PNETs. METHODS:A retrospective review of patients pathologically diagnosed with PNETs at our institution from January 2012 to January 2014 was conducted. Tumor specimens were stained by immunochemistry for MMP-9, DJ-1, A1BG, and Ki-67. Clinicopathologic findings and these 4 tumor markers of patients with PNETs were analyzed. Prognostic factors were determined by univariate and multivariate analyses. RESULTS:A total of 40 patients were selected. Of 40 tumors, 19 (47.5%) were positive for MMP-9, 21 (52.5%) for DJ-1, 18 (45%) for A1BG, and 24 (60%) for Ki-67 > 2%. Four (10%) tumors expressed none of the markers. MMP-9 and DJ-1 expression were more frequently observed in distant metastasis, higher WHO grade, and lymph node metastasis. Similarly, those with Ki-67 > 2% had larger tumor, higher WHO grade, lymph node invasion and larger surgical procedures. A1BG had no substantial effect on distant metastasis. Univariate analyses revealed that grade 2/3 histology, distant metastasis, lymph nodes metastasis, high expression of MMP-9, high expression of DJ-1, and Ki-67 > 2% were predictive of inferior disease-free survival for PNETs (all p < 0.05). In multivariable analysis, the significant poor factors associated with disease-free survival were grade 2/3 histology, distant metastasis, lymph node metastasis, and Ki-67 > 2% (all p < 0.05). CONCLUSIONS:Of the 4 markers studied, only Ki-67 was the independent prognostic factor. Expression of MMP-9 and DJ-1 correlated with invasion, metastasis, disease progression, and poor prognosis in PNETs, while A1BG had no prognostic value in PNETs. It is anticipated that these findings can serve as useful clinical survival predictors, especially in the setting of resected disease.

Grading Solid Pseudopapillary Tumors of the Pancreas: the Fudan Prognostic Index

Solid pseudopapillary tumor of the pancreas: a review of 553 cases in Chinese literature.

Prognostic Value of Ki-67 in Solid Pseudopapillary Tumor of the Pancreas: Huashan Experience and Systematic Review of the Literature.

Prediction of Malignancy and Adverse Outcome of Solid Pseudopapillary Tumor of the Pancreas

Prognostic significance of grade of malignancy based on histopathological differentiation and Ki-67 in pancreatic ductal adenocarcinoma

Comparison of Tumor Markers for Predicting Disease-Free Survival in Surgically Resected Pancreatic Neuroendocrine Tumors

One Hundred Twenty-One Resected Solid Pseudopapillary Tumors of the Pancreas

How Reliable is the Ki-67 Cytological Index in Grading Pancreatic Neuroendocrine Tumors? A Meta-Analysis

[Study on Clinicopathologic Features and Metastasizing Potential of Solid Pseudopapillary Tumor of Pancreas].

Meta-analysis of Ki-67 Expression for Recurrence in Patients with Solid Pseudopapillary Tumor of the Pancreas.

Prognostic Enigma of Pancreatic Solid Pseudopapillary Neoplasm: A Single-Center Experience of 63 Patients

Ki-67 is Predictive for Prognosis of Solid Pseudopapillary Tumor of the Pancreas

Number of Positive Lymph Nodes is Superior to LNR and LODDS for Predicting the Prognosis of Pancreatic Neuroendocrine Neoplasms

Comprehensive analysis of factors that involve in survival and prognosis in patients with gastrointestinal stromal tumors

Equipping the American Joint Committee on Cancer Staging for Resectable Pancreatic Ductal Adenocarcinoma with Tumor Grade: A Novel Staging System

Preoperative neutrophil-to-lymphocyte ratio predicts malignancy and recurrence-free survival of solid pseudopapillary tumor of the pancreas.

Prognostic Factors and Survival in 324 Patients with Pancreatic Endocrine Tumor Treated at a Single Institution

A Novel Scoring System Predicts Postsurgical Survival and Adjuvant Chemotherapeutic Benefits in Patients with Pancreatic Adenocarcinoma: Implications for AJCC-TNM Staging

[Accurate Grading of Pancreatic Neuroendocrine Tumors with Ki-67 Index in Fine-Needle Aspiration Specimens: a Comparative Cytologic and Histologic Study].

Solid Pseudopapillary Neoplasms of the Pancreas: Clinicopathologic Analysis and a Predictive Model

AB124. P100. The prevalence and characteristics of pancreatic solid pseudopapillary tumor associate with malignance: a multicenter retrospective study in China